U.S. Capital Markets Stock News

Investors in Schneider National, Inc. ( NYSE:SNDR ) had a good week, as its shares rose 3.9% to close at US$31.47...

If you are wondering whether Acadian Asset Management is still attractively priced after a strong run, the starting point is understanding what the current market price is implying about the business. The stock closed at US$65.49, with recent returns of 18.5% over 30 days, 38.2% year to date, and 135.9% over 1 year, although the last 7 days showed a 3.4% decline. Recent coverage has focused on Acadian Asset Management's share price performance and how investors are reacting to changing...

Those following along with CECO Environmental Corp. ( NASDAQ:CECO ) will no doubt be intrigued by the recent purchase...

Shareholders might have noticed that AptarGroup, Inc. ( NYSE:ATR ) filed its first-quarter result this time last week...

L3Harris Technologies, Inc. ( NYSE:LHX ) just released its latest first-quarter results and things are looking bullish...

It's been a sad week for Insperity, Inc. ( NYSE:NSP ), who've watched their investment drop 13% to US$28.53 in the week...

Even though Betterware de México, S.A.P.I. de C.V. ( NYSE:BWMX ) posted strong earnings, investors appeared to be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like German American Bancorp, Inc. ( NASDAQ:GABC ) is about to go ex-dividend in the next four days. The...

It looks like Franklin Electric Co., Inc. ( NASDAQ:FELE ) is about to go ex-dividend in the next 3 days. The...

If you are wondering whether Vistance Networks at US$11.93 is still priced attractively after a big run, the current setup gives you a lot to weigh up before making any moves. The stock has pulled back sharply in the short term, with a 38.5% decline over 7 days and a 36.3% decline over 30 days, even after very strong 413.6% 1 year and 411.5% 3 year returns. These swings have brought the stock back into focus for valuation minded investors who are weighing up whether the recent weakness is a...

If you are wondering whether Capital Clean Energy Carriers at around US$20.61 is a bargain or already pricing in its story, you will want to understand how its current price lines up with different valuation checks. The stock has returned 4.0% over the last week, 9.9% over the last month, 1.0% year to date and 7.3% over the last year. This gives you some context around how sentiment has been shifting. Recent coverage has focused on Capital Clean Energy Carriers as part of broader discussions...

Wondering whether GameStop at around US$26.53 is a bargain, fairly priced, or still riding on hype? This breakdown is designed to help you weigh what the current share price might be reflecting. The stock has seen short term moves, with returns of 6.3% over the last 7 days, 13.6% over the last 30 days, 28.7% year to date, and a 2.3% decline over the last year. The 3 year return sits at 31.4% and the 5 year return at a 33.4% decline. These swings continue to be shaped by recurring attention...

If you are wondering whether Sterling Infrastructure at US$532.67 is priced for perfection or still offers value, this article walks through the numbers in plain English. The stock has delivered returns of 7.1% over the last 7 days, 27.9% over 30 days, 66.9% year to date and 221.6% over 1 year, with a very large 3 year and 5 year gain that is well above 7x. Recent coverage has focused on Sterling Infrastructure's role in capital goods and construction projects across the US, as investors...

Pacira BioSciences, Inc. recently reported first-quarter 2026 results showing revenue of US$177.38 million, up from US$168.92 million a year earlier, while net income eased to US$2.92 million and diluted EPS to US$0.07. Alongside these results, the company highlighted real-world Medicare data for EXPAREL showing reduced opioid use and medical costs after outpatient hip replacements, while an activist proxy battle with DOMA Perpetual Capital Management adds a governance twist ahead of the...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hess...

It looks like First Bank ( NASDAQ:FRBA ) is about to go ex-dividend in the next four days. Typically, the ex-dividend...

Some First Financial Bancorp. ( NASDAQ:FFBC ) shareholders may be a little concerned to see that the Chairman of the...

Anyone interested in Pathward Financial, Inc. ( NASDAQ:CASH ) should probably be aware that the Independent Director...

We wouldn't blame Adobe Inc. ( NASDAQ:ADBE ) shareholders if they were a little worried about the fact that Shantanu...

Universal Insurance Holdings, Inc. ( NYSE:UVE ) is about to trade ex-dividend in the next four days. The ex-dividend...

Timken (NYSE:TKR) agreed to sell its belts business to Gates Industrial in a transaction expected to close in the third quarter. The deal is intended to sharpen Timken’s focus on core operations and support margin improvement in its Industrial Motion segment. Transaction proceeds are planned to fund Timken’s broader capital allocation priorities. For you as an investor, this move sits at the intersection of two industrial names that both operate across power transmission and motion control...

Wondering if Acadia Healthcare Company at around US$27.85 is a bargain or a value trap? This article walks through what the current price might be implying. The stock has returned 1.7% over the past week, 16.2% over the last month, 94.9% year to date and 19.5% over the past year, while the 3 year and 5 year returns of 59.7% and 56.5% declines show that longer term holders have had a very different experience. Recent coverage has focused on Acadia Healthcare Company as a specialist in...

Azenta has appointed Trey (William E.) Martin III as President of its Multiomics business, with former president Ginger Zhou remaining as an advisor through November 2026, and granted him 17,790 time-vested RSUs that will vest in equal annual tranches from April 2027 to April 2029. This leadership transition in a core growth area, coupled with equity-based incentives, signals how Azenta is aligning executive oversight and compensation with its long-range Multiomics ambitions. Next, we’ll...